$360 Million Raised in 1.5 Years: AusperBio Banks Series C to Accelerate a Functional Cure for Hepatitis B
Details
$1.045 Billion! Duality Biologics Teams Up with Genentech
Zecui Biotech Completes $75M Round, Scaling Oncology & Metabolic Cell Therapy
Over €423.5M: IMPACT Therapeutics Out-Licenses PARP Inhibitor Senaparib to Pharmanovia
The Brain Imaging Race Heats Up — Bay Imaging Lands Strategic Round to Scale Next-Gen Brain PET
$1.5 Billion Blockbuster: Dizal Hands Sunvozertinib Global Keys to AstraZeneca
Sonosemi Raises Series B+ Financing to Accelerate Global Expansion in Intelligent Vascular Intervention
Novartis to Acquire Myricx Bio for Up to $1.1B, Strengthening Next-Generation ADC Innovation
$62 million Series B financing to develop a licensed trispecific T-cell engager (TCE) from Leads Biolabs.
Nearly $2 Billion Deal! Chinese-Origin TCE Secures Another Overseas Licensing Agreement
